alrise.de bewertung und analyse
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | ALRISE Biosystems GmbH, Competence in Drug |
| Description | ALRISE Biosystems GmbH is a drug delivery company with focus on the development of controlled-release formulations. For this purpose, the company makes use of its novel and world-wide patented technology for advanced nano- and microencapsulation of |
| Keywords | ALRISE, Alrise, Albayrak, Rindler, Seemann, Berlin, Buch, Campus, Pharma, Technological, Pharmaceutical, Controlled, Release, Depot, Formulation, Initial, Burst, Micro, Nano, Particle, Biodegradable, Solution, Polymer, Vitro, Vivo, Profile |
Server Information
| WebSite | |
| Host IP | 45.91.213.7 |
| Location | - |
Mehr zu entdecken
alrise.de bewertung
|
Euro€3,306
Zuletzt aktualisiert: 2022-06-30 21:58:56
alrise.de hat Semrush globalen Rang von 8,083,791. alrise.de hat einen geschätzten Wert von € 3,306, basierend auf seinen geschätzten Werbeeinnahmen. alrise.de empfängt jeden Tag ungefähr 551 einzelne Besucher. Sein Webserver befindet sich in - mit der IP-Adresse 45.91.213.7. Laut SiteAdvisor ist alrise.de sicher zu besuchen. |
Verkehr & Wertschätzungen
| Kauf-/Verkaufswert | Euro€3,306 |
| Tägliche Werbeeinnahmen | Euro€98,078 |
| Monatlicher Anzeigenumsatz | Euro€33,060 |
| Jährliche Werbeeinnahmen | Euro€2,204 |
| Tägliche eindeutige Besucher | 551 |
| Hinweis: Alle Traffic- und Einnahmenwerte sind Schätzungen. | |
DNS Records
| Host | Type | TTL | Data |
| alrise.de. | A | 3600 | IP: 45.91.213.7 |
| alrise.de. | NS | 3600 | NS Record: ns01.cecon.de. |
| alrise.de. | NS | 3600 | NS Record: ns02.cecon.de. |
| alrise.de. | MX | 3600 | MX Record: 10 mail01.cecon.de. |
| alrise.de. | MX | 3600 | MX Record: 20 mail02.cecon.de. |
HtmlToTextCheckTime:2022-06-30 21:58:56
| Home Imprint Sitemap Datenschutz Privacy Policy Print News Jobs Contact ALRISE Biosystems GmbH is a drug-delivery company focused on advanced micro encapsulation of pharmaceutically active ingredients. ALRISE’s core business includes the development of long-acting injectable depot products for controlled release applications. ALRISE’s mission is to make its highly innovative and world-wide patented encapsulation technology available to a broader user spectrum as well as to create benefits for patients worldwide. ALRISE Biosystems GmbH Robert-Roessle-Strae 10 Otto-Warburg-Haus 13125 Berlin, Germany Phone +49 30.94 89 24 83 Fax +49 30.94 89 24 82 eMail info@alrise.de Top © 2006 - 2021 ALRISE Biosystems GmbH Home | Imprint | Sitemap | Datenschutz | Privacy Policy | |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Wed, 27 Oct 2021 06:33:45 GMT Server: Apache/2.4.41 (Ubuntu) Location: https://alrise.de/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Wed, 27 Oct 2021 06:33:46 GMT Server: Apache/2.4.41 (Ubuntu) Last-Modified: Mon, 21 Dec 2020 21:19:58 GMT ETag: "1386-5b7000528db80" Accept-Ranges: bytes Content-Length: 4998 Vary: Accept-Encoding Content-Type: text/html |